Wille Finance

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

T3 Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, founded in 2015. The company focuses on the research and development of innovative bacteria-based therapies aimed at treating cancer. Recognizing the ongoing need for novel treatments despite advancements in classical therapies, T3 Pharmaceuticals aims to enhance the lives of cancer patients by developing highly specific and efficient immuno-oncology therapies. Their proprietary approach utilizes a bacterial type III secretion system to deliver therapeutic proteins directly to solid tumors, providing a potential breakthrough in cancer treatment.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Labiotech UG operates Labiotech.eu, a prominent online platform dedicated to news and insights in the biotechnology sector across Europe. Established in 2014 and based in Berlin, the website covers a wide range of topics, including health, non-health, research, finance, and market access, featuring articles, interviews, reviews, and industry highlights. Labiotech.eu serves as a valuable resource for those interested in the latest developments and innovations in biotechnology, cell therapy, cancer research, and mental health. The platform not only provides news but also offers advertising opportunities, catering to a diverse audience in multiple European countries, including Germany, France, the United Kingdom, and many others. Through its comprehensive content, Labiotech.eu aims to keep readers informed about the dynamic landscape of the biotech industry.

Nezasa is a developer of a travel optimization platform that enables travel brands to offer a comprehensive booking solution for multi-product and multi-stop itineraries. By combining the functionalities of a traditional travel agency with the efficiency of an online portal, Nezasa's tools facilitate seamless planning and real-time booking of personalized trips. Their TripBuilder feature allows users to create hyper-personalized travel packages, while TripBooster extends these capabilities to enhance in-destination upselling opportunities. The platform leverages standardized and customizable application programming interfaces hosted in a secure cloud environment, making it easy for tour operators and travel retailers to automate the customization and booking processes for their clients. With a focus on deep integration and an interactive user experience, Nezasa caters to large travel operators, providing them with enterprise-grade solutions to enhance their service offerings throughout the entire travel lifecycle.

Nezasa is a developer of a travel optimization platform that enables travel brands to offer a comprehensive booking solution for multi-product and multi-stop itineraries. By combining the functionalities of a traditional travel agency with the efficiency of an online portal, Nezasa's tools facilitate seamless planning and real-time booking of personalized trips. Their TripBuilder feature allows users to create hyper-personalized travel packages, while TripBooster extends these capabilities to enhance in-destination upselling opportunities. The platform leverages standardized and customizable application programming interfaces hosted in a secure cloud environment, making it easy for tour operators and travel retailers to automate the customization and booking processes for their clients. With a focus on deep integration and an interactive user experience, Nezasa caters to large travel operators, providing them with enterprise-grade solutions to enhance their service offerings throughout the entire travel lifecycle.

Nezasa is a developer of a travel optimization platform that enables travel brands to offer a comprehensive booking solution for multi-product and multi-stop itineraries. By combining the functionalities of a traditional travel agency with the efficiency of an online portal, Nezasa's tools facilitate seamless planning and real-time booking of personalized trips. Their TripBuilder feature allows users to create hyper-personalized travel packages, while TripBooster extends these capabilities to enhance in-destination upselling opportunities. The platform leverages standardized and customizable application programming interfaces hosted in a secure cloud environment, making it easy for tour operators and travel retailers to automate the customization and booking processes for their clients. With a focus on deep integration and an interactive user experience, Nezasa caters to large travel operators, providing them with enterprise-grade solutions to enhance their service offerings throughout the entire travel lifecycle.